Mektovi (Binimetinib)

Brand Options

arrow pointer

Brand Name : Mektovi

Marketing Authorization Holder : Array BioPharma

Prescription Required

No Generic Medicine available for this medicine.

Product Details


Save over 50% on European Mektovi.

Non-english packaging - English label and English insert included. Plan in advance - allow us 7 days to ship your medicine

Manufacturer of European Mektovi:
Site Progipharm, Rue du Lycée 
45500 GIEN 


Mektovi is used to treat skin cancer (melanoma) in adults in combination with Braftovi (containing encorafenib).  This combination may slow down or stop cancer growth.

Mektovi is recommended at a dose of 90mg daily, as 45 mg (three 15 mg tablets) twice daily (12 hours apart).  In order to manage adverse reactions, dose reduction, interruption of therapy or treatment stoppage be required.

Image Image Image Image